COUP-TFII (NR2F2), an ONR of the highly conserved NR2F subfamily, displays an increased expression pattern in advanced prostate cancer, and its expression is positively correlated with prostate tumor recurrence and progression [70–72]. Here, NR2F2 is linked to prostate carcinoma.